CATALOGO DEI PRODOTTI DELLA RICERCA

BUSTI, Fabiana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.659
EU - Europa 3.477
AS - Asia 2.503
SA - Sud America 423
AF - Africa 93
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.167
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.581
RU - Federazione Russa 1.490
SG - Singapore 938
CN - Cina 722
GB - Regno Unito 589
BR - Brasile 332
IT - Italia 296
VN - Vietnam 258
HK - Hong Kong 227
SE - Svezia 224
DE - Germania 196
FR - Francia 172
IE - Irlanda 162
FI - Finlandia 138
KR - Corea 96
JP - Giappone 45
CA - Canada 43
IN - India 42
NL - Olanda 38
UA - Ucraina 35
AR - Argentina 34
BD - Bangladesh 28
BE - Belgio 27
ID - Indonesia 27
ZA - Sudafrica 23
IQ - Iraq 21
ES - Italia 20
TR - Turchia 20
MX - Messico 18
NG - Nigeria 16
PK - Pakistan 16
PL - Polonia 16
AT - Austria 11
CL - Cile 11
EC - Ecuador 11
IR - Iran 10
TG - Togo 10
VE - Venezuela 10
EG - Egitto 9
LT - Lituania 9
BJ - Benin 8
UZ - Uzbekistan 8
AU - Australia 7
CZ - Repubblica Ceca 7
BO - Bolivia 6
CH - Svizzera 6
CO - Colombia 6
GR - Grecia 6
DZ - Algeria 5
JO - Giordania 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
DO - Repubblica Dominicana 4
HR - Croazia 4
KG - Kirghizistan 4
NP - Nepal 4
OM - Oman 4
PE - Perù 4
PY - Paraguay 4
SA - Arabia Saudita 4
BA - Bosnia-Erzegovina 3
CY - Cipro 3
EU - Europa 3
HN - Honduras 3
PH - Filippine 3
RO - Romania 3
SN - Senegal 3
TN - Tunisia 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
LV - Lettonia 2
MA - Marocco 2
MD - Moldavia 2
MT - Malta 2
MY - Malesia 2
PA - Panama 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
EE - Estonia 1
GY - Guiana 1
IM - Isola di Man 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
Totale 10.155
Salva come PNG Salva come JPEG
Città #
Moscow 505
Singapore 491
Ashburn 478
Southend 463
Chandler 416
San Jose 340
Dallas 294
Jacksonville 227
Hong Kong 218
Ann Arbor 164
Dublin 160
Beijing 138
Verona 135
Woodbridge 130
New York 122
The Dalles 104
Ho Chi Minh City 85
Los Angeles 69
Houston 66
Wilmington 66
Lawrence 59
Princeton 59
Munich 52
Helsinki 48
Jinan 43
Boardman 40
Nanjing 40
Tokyo 38
Hanoi 36
São Paulo 36
Redondo Beach 34
Santa Clara 28
Buffalo 27
Council Bluffs 27
Shenyang 27
Brussels 25
London 24
Orem 23
Turku 21
Lancaster 20
Redmond 20
Falkenstein 19
Tianjin 19
Haikou 18
Seoul 18
Sindelfingen 18
Zhengzhou 18
Brooklyn 17
Hebei 17
Columbus 16
Falls Church 16
Nanchang 16
Ningbo 16
Chennai 15
Milan 15
Montreal 15
Poplar 15
Seattle 15
Denver 14
Frankfurt am Main 14
Abuja 13
Changsha 13
Warsaw 13
Bologna 12
Guangzhou 12
Haiphong 12
Jakarta 12
Lappeenranta 12
Nuremberg 12
Rome 12
San Francisco 12
Amsterdam 11
Johannesburg 11
Rio de Janeiro 11
Taiyuan 11
Taizhou 11
Toronto 11
Chicago 10
Dhaka 10
Lomé 10
Redwood City 10
Atlanta 9
City of London 9
Fuzhou 9
Hangzhou 9
Jiaxing 9
Madrid 9
Phoenix 9
Boston 8
Cotonou 8
Da Nang 8
Norwalk 8
Tashkent 8
Vienna 8
Belo Horizonte 7
Lanzhou 7
Stockholm 7
Tehran 7
Villarbasse 7
Fairfield 6
Totale 6.102
Salva come PNG Salva come JPEG
Nome #
A challenging case of abdominal pain associated to Helicobacter pylori infection 238
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 235
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 206
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 205
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload 204
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 201
Identification of new BMP6 pro-peptide mutations in patients with iron overload 196
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 196
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 195
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 193
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian Patients with Iron Overload and Non-Diagnostic First Level Genetic Test: A Pilot Study 190
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 188
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 188
Altered paraoxonase expression in patients with genetic haemochromatosis. 186
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 184
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 183
Genomics of coronary artery disease and myocardial infarction. From Genome Wide Association Studies to the Next-Generation-Sequencing era 180
Paraoxonase-1 status in patients with hereditary hemochromatosis 174
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 172
Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis 169
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 166
COBALAMIN DEFICIENCY IN THE ELDERLY 165
Hepcidin suppression relative to iron status in patients with chronic Hepatitits C 162
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 157
Serum Hepcidin Levels Correlate with Phenotypes of the Metabolic Syndrome At Population Level 155
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.c282y homozygous patients. 150
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 149
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 148
HEPCIDIN SUPPRESSION IN BETA-THALASSEMIA CARRIERS WITH IRON OVERLOAD. Preliminary reports from an ongoing study. 147
DISHphagia: An Unusual Cause of Dysphagia. J Clin Endocrinol Metab. 146
Practical implications of the 2019 Nobel Prize in Physiology or Medicine: from molecular adaptation to hypoxia to novel anti-anemic drugs in the clinic 145
Iron replacement therapy: entering the new era without misconceptions, but more research is needed 143
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 143
An unusual case of inferior vena cava thrombosis: widening the differential diagnosis 141
Anemia and adverse outcomes in the elderly: a detrimental inflammatory loop? 141
Modern iron replacement therapy: clinical and pathophysiological insights 139
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease but not with mortality in the setting of secondary prevention 135
Reduced serum hepcidin levels in patients with chronic hepatitis C 133
Iron replacement in inflammatory bowel disease: an evolving scenario 132
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 129
Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach 124
Anemia and iron deficiency in heart failure: extending evidences from chronic to acute setting 123
Iron metabolism in infections: Focus on COVID-19 120
GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors 119
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 114
Treatment options for anemia in the elderly 114
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches 113
Hyperferritinemia and diagnosis of type 1 Gaucher disease 113
Is Ferroptosis a Key Component of the Process Leading to Multiorgan Damage in COVID-19? 109
Therapeutic oligonucleotides in cardiovascular and metabolic diseases: insights for the internist 108
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study 104
Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease 104
A case series of patients with β-thalassemia trait and iron overload: from multifactorial hepcidin suppression to treatment with mini-phlebotomies 103
Proprotein convertase 7 rs236918 is associated with liver fibrosis in Italian patients with HFE-related Hemochromatosis 102
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease 102
Paraoxonase-1 status in patients with hereditary hemochromatosis. 101
The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study 100
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 99
Iron deficiency in the elderly population, revisited in the hepcidin era. 94
Impact of natural Neuromedin-B receptor variants on iron metabolism 94
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? 94
Serum Erythroferrone in a Large General Population: Towards a Better Understanding of Connections Between Erythropoiesis and Iron Homeostasis 92
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian patients with Iron Overload and Non-diagnostic First Level Genetic Test.A Pilot Study 88
Use of non-invasive respiratory supports in high-intensity internal medicine setting during the first two waves of the COVID-19 pandemic emergency in Italy: a multicenter, real-life experience 87
Diagnosis and management of hereditary hemochromatosis: lifestyle modification, phlebotomy, and blood donation 84
Hemochromatosis classification: update and recommendations by the BIOIRON Society 84
Clonal hematopoiesis in cardiovascular aging: Insights from the verona heart study 80
Inflammation and iron homeostasis - what do blood tests mean? 79
New Insights into the Role of Ferroptosis in Cardiovascular Diseases 76
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study 74
ERFE regulation in sickle cell disease: complex but promising 74
Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments 74
The Role of Iron Staining in Myelodysplastic Syndromes: A Treasure Trove of Information 68
Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia 57
Sparing unnecessary transfusions through patient blood management: time for application also in internal and emergency medicine 56
Manipulating hepcidin in polycythemia vera 51
Recent Advancements in Hematology: Knowledge, Methods and Dissemination-1 46
Recent Advancement of Hematology: Know, How to Do, Let Know 44
Totale 10.277
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.799
article - articoli 24.628
book - libri 0
conference - conferenze 7.753
curatela - curatele 0
other - altro 418
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.598
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202193 0 0 0 0 0 0 0 0 0 18 50 25
2021/2022530 15 159 3 63 20 23 7 28 20 17 50 125
2022/20231.143 67 132 94 198 100 254 22 87 139 4 24 22
2023/2024665 21 36 49 58 54 149 21 48 7 32 96 94
2024/20251.570 82 111 65 255 71 50 94 71 195 94 150 332
2025/20264.708 321 267 356 909 1.332 260 394 235 375 259 0 0
Totale 10.277